AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Bioceres Crop Solutions Corp.

$0.43 -$0.92 (-68.28%)
NASDAQ · 14 Sep 2026 20:00 UTC
Previous Close
$0.42
Day Range
$0.41$0.44
Year Range
$0.3$2.19
Market Cap
27.07M
AVG Volume
277.53K
Trailing/Forward PE
-0.11/8.56
PEG ratio
-0
Dividend Yield
-
Next Earnings Date
2026-11-17
Primary Exchange
NASDAQUS
Revenue (USD) · TTM
0200M400M600M24 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
BIOX Revenue (USD) · TTM by quarter
PeriodRevenue (USD) · TTM
26 Q3263.68M
26 Q2285.07M
26 Q1310.28M
25 Q4325.47M
25 Q3375.41M
25 Q2399.82M
25 Q1441.23M
24 Q4464.8M
24 Q3445.55M
24 Q2454.54M
Net Income (USD) · TTM
-300M-200M-100M0100M24 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
BIOX Net Income (USD) · TTM by quarter
PeriodNet Income (USD) · TTM
26 Q3-250.55M
26 Q2-239.56M
26 Q1-56.37M
25 Q4-55.42M
25 Q3-9.06M
25 Q21.5M
25 Q11.47M
24 Q43.24M
24 Q33.07M
24 Q222.01M
Operating Income (USD) · TTM
020M40M60M24 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
BIOX Operating Income (USD) · TTM by quarter
PeriodOperating Income (USD) · TTM
26 Q32.17M
26 Q29.6M
26 Q116.97M
25 Q412.87M
25 Q329.27M
25 Q241.54M
25 Q143.15M
24 Q444.78M
24 Q340.4M
24 Q257.07M
EBITDA (USD) · TTM
-25M025M50M75M24 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
BIOX EBITDA (USD) · TTM by quarter
PeriodEBITDA (USD) · TTM
26 Q3-20.12M
26 Q2-10.39M
26 Q1-3.27M
25 Q4-8.38M
25 Q333.58M
25 Q247.04M
25 Q152.79M
24 Q458.5M
24 Q355.29M
24 Q269.67M
Cash Flows (USD) · TTM
-25M025M50M75M24 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
BIOX Cash Flows (USD) · TTM by quarter
PeriodCash Flows (USD) · TTM
26 Q354.77M
26 Q272.19M
26 Q146.29M
25 Q435.3M
25 Q327.91M
25 Q2-12.89M
25 Q112.22M
24 Q418.93M
24 Q3-13.32M
24 Q26.14M
EPS (USD) · TTM
-4-20224 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
BIOX EPS (USD) · TTM by quarter
PeriodEPS (USD) · TTM
26 Q3-3.89
26 Q2-3.72
26 Q1-0.84
25 Q4-0.81
25 Q3-0.13
25 Q20.03
25 Q10.03
24 Q40.04
24 Q30.04
24 Q20.35
Expenses (USD) · TTM
050M100M150M200MR&DSG&ACapex24 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
BIOX Expenses (USD) · TTM by quarter
PeriodExpenses (USD) · TTM
26 Q366.31M
26 Q296.9M
26 Q1104.55M
25 Q4109.6M
25 Q3116.11M
25 Q2125.8M
25 Q1142.52M
24 Q4151.17M
24 Q3130.5M
24 Q2124.21M
Shares Outstanding (USD) · TTM
-15M-10M-5M05MBuybacks (Repurchases)Stock-Based Compensation24 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
BIOX Shares Outstanding (USD) · TTM by quarter
PeriodShares Outstanding (USD) · TTM
26 Q3-1.13M
26 Q2-2.18M
26 Q1-2.65M
25 Q4-3.46M
25 Q3-5.08M
25 Q2-6.89M
25 Q1-8.47M
24 Q4-13.4M
24 Q3-11M
24 Q2-8.44M
Employee Count
02505007501K2019202020212022202320242025
BIOX Employee Count by quarter
PeriodEmployee Count
2025751
2024983
2023790
2022565
2021497
2020447
2019409
PE Ratio
0100200300400med 148.58Sep 23Jan 24Apr 24Aug 24Nov 24Feb 25Jun 25
BIOX PE Ratio by quarter
PeriodPE Ratio
Jun 25183.34
Jun 25211.39
May 25204.27
May 25193.81
May 25194.64
May 25197.15
May 25192.13
Apr 25179.99
Apr 25173.29
Apr 25182.5
Apr 25172.88
Mar 25205.11
Mar 25182.5
Mar 25193.81
Mar 25217.25
Feb 25168.27
Feb 25195.11
Feb 25212.69
Feb 25237.99
Jan 25293.73
Jan 25307.88
Jan 25295.45
Jan 25280.44
Jan 25274.43
Dec 24272.29
Dec 24265.43
Dec 24285.58
Dec 24278.29
Nov 24305.31
Nov 24114.52
Nov 24115.26
Nov 24119.37
Nov 24121.24
Oct 24143.36
Oct 24154.62
Oct 24153.8
Oct 24159.13
Sep 24160.76
Sep 24168.75
Sep 24175.3
Sep 24206.84
Aug 24217.9
Aug 24203.77
Aug 24208.48
Aug 24204.79
Aug 24207.25
Jul 24226.3
Jul 24228.76
Jul 24229.78
Jul 24229.37
Jun 24229.57
Jun 24217.08
Jun 24220.97
Jun 24218.72
May 24241.25
May 2431.26
May 2432.86
May 2436.86
May 2434.66
Apr 2434.4
Apr 2434.6
Apr 2435.69
Apr 2436.12
Mar 2436.15
Mar 2435.98
Mar 2436.52
Mar 2437.8
Mar 2438.14
Feb 2459.9
Feb 2460.27
Feb 2462.05
Feb 2457.89
Jan 2462.42
Jan 2462.37
Jan 2463.33
Jan 2460.91
Dec 2362.78
Dec 2362.42
Dec 2361.82
Dec 2357.98
Dec 2356.52
Nov 2355.69
Nov 2353.68
Nov 2334.44
Nov 2335.66
Oct 2336.48
Oct 2335.34
Oct 2335.38
Oct 2334.98
Sep 2337.64
Sep 2337.11
Sep 2337.38
Sep 2337.54
Sep 2340.21
Aug 2344.6
Aug 2344.28
Aug 2347.6
Aug 2349.11
Jul 2350.27
Jul 2352.51
Free Cash Flow Yield
-100%0%100%200%300%400%med 25.49%Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
BIOX Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 26201.1%
Sep 26205.46%
Sep 26198.46%
Aug 26210.03%
Aug 26195.31%
Aug 26191.78%
Aug 26250.1%
Jul 26239.26%
Jul 26251.05%
Jul 26245.96%
Jul 26250.9%
Jul 26260.15%
Jun 26257.35%
Jun 26230.92%
Jun 26205.02%
Jun 26204.93%
May 26193.12%
May 26208.05%
May 26200.72%
May 26241.88%
May 26242.97%
Apr 26210.15%
Apr 26191.37%
Apr 26206.41%
Apr 26210.5%
Mar 26290.88%
Mar 26305.73%
Mar 26215.57%
Mar 26136.22%
Feb 26130.31%
Feb 26122.85%
Feb 26124.43%
Feb 26129.14%
Jan 2687.1%
Jan 2660.81%
Jan 2656.57%
Jan 2657.92%
Jan 2654.06%
Dec 2555.28%
Dec 2552.13%
Dec 2546.48%
Dec 2548.65%
Nov 2542.43%
Nov 2537.48%
Nov 2533.24%
Nov 2524.83%
Oct 2521.9%
Oct 2524.16%
Oct 2526.15%
Oct 2531.08%
Oct 2533.17%
Sep 2529.63%
Sep 2526.62%
Sep 2521.79%
Sep 2516.4%
Aug 2515.93%
Aug 2515.17%
Aug 2515.07%
Aug 2514.34%
Aug 2512.81%
Jul 2511.85%
Jul 2512.31%
Jul 2510.51%
Jul 259%
Jun 259.9%
Jun 259.79%
Jun 25-4.68%
Jun 25-4.06%
May 25-4.2%
May 25-4.43%
May 25-4.41%
May 25-4.36%
May 25-4.47%
Apr 25-4.77%
Apr 25-4.96%
Apr 25-4.71%
Apr 25-4.97%
Mar 25-4.19%
Mar 25-4.71%
Mar 25-4.43%
Mar 25-3.95%
Feb 25-5.1%
Feb 254.27%
Feb 253.92%
Feb 253.5%
Jan 252.84%
Jan 252.71%
Jan 252.82%
Jan 252.97%
Jan 253.04%
Dec 243.06%
Dec 243.14%
Dec 242.92%
Dec 242.99%
Nov 242.73%
Nov 245.1%
Nov 245.06%
Nov 244.89%
Nov 244.82%
Oct 24-3.03%
Price to Sales
00.250.50.7511.25med 0.32Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
BIOX Price to Sales by quarter
PeriodPrice to Sales
Sep 260.1
Sep 260.1
Sep 260.1
Aug 260.1
Aug 260.11
Aug 260.11
Aug 260.08
Jul 260.09
Jul 260.08
Jul 260.08
Jul 260.08
Jul 260.08
Jun 260.08
Jun 260.09
Jun 260.1
Jun 260.1
May 260.11
May 260.1
May 260.1
May 260.1
May 260.1
Apr 260.12
Apr 260.13
Apr 260.12
Apr 260.12
Mar 260.09
Mar 260.08
Mar 260.12
Mar 260.11
Feb 260.11
Feb 260.12
Feb 260.12
Feb 260.12
Jan 260.17
Jan 260.25
Jan 260.26
Jan 260.26
Jan 260.28
Dec 250.27
Dec 250.29
Dec 250.32
Dec 250.31
Nov 250.35
Nov 250.29
Nov 250.33
Nov 250.3
Oct 250.34
Oct 250.31
Oct 250.28
Oct 250.24
Oct 250.22
Sep 250.25
Sep 250.28
Sep 250.34
Sep 250.45
Aug 250.47
Aug 250.49
Aug 250.49
Aug 250.52
Aug 250.58
Jul 250.63
Jul 250.6
Jul 250.71
Jul 250.83
Jun 250.75
Jun 250.76
Jun 250.69
Jun 250.79
May 250.77
May 250.73
May 250.73
May 250.74
May 250.72
Apr 250.68
Apr 250.65
Apr 250.69
Apr 250.65
Mar 250.77
Mar 250.69
Mar 250.73
Mar 250.82
Feb 250.63
Feb 250.65
Feb 250.71
Feb 250.79
Jan 250.98
Jan 251.02
Jan 250.98
Jan 250.93
Jan 250.91
Dec 240.9
Dec 240.88
Dec 240.95
Dec 240.92
Nov 241.01
Nov 240.8
Nov 240.8
Nov 240.83
Nov 240.85
Oct 240.99
EV/EBITDA
510152025med 12.82Feb 24May 24Sep 24Dec 24Apr 25Jul 25Nov 25
BIOX EV/EBITDA by quarter
PeriodEV/EBITDA
Nov 2510.31
Oct 2510.76
Oct 2510.41
Oct 2510.15
Oct 259.64
Oct 259.47
Sep 259.77
Sep 2510.09
Sep 2510.78
Sep 2512.04
Aug 2512.19
Aug 2512.45
Aug 2512.48
Aug 2512.76
Aug 2513.46
Jul 2513.98
Jul 2513.72
Jul 2514.88
Jul 2516.21
Jun 2515.36
Jun 2515.46
Jun 2511.26
Jun 2512.15
May 2511.93
May 2511.59
May 2511.62
May 2511.7
May 2511.54
Apr 2511.15
Apr 2510.94
Apr 2511.23
Apr 2510.93
Mar 2511.95
Mar 2511.23
Mar 2511.59
Mar 2512.34
Feb 2510.78
Feb 259.74
Feb 2510.23
Feb 2510.93
Jan 2512.48
Jan 2512.88
Jan 2512.53
Jan 2512.11
Jan 2511.95
Dec 2411.89
Dec 2411.7
Dec 2412.26
Dec 2412.05
Nov 2412.8
Nov 2410.02
Nov 2410.06
Nov 2410.29
Nov 2410.39
Oct 2411.97
Oct 2412.6
Oct 2412.55
Oct 2412.85
Sep 2412.94
Sep 2413.38
Sep 2413.74
Sep 2415.49
Aug 2416.11
Aug 2415.32
Aug 2415.58
Aug 2415.38
Aug 2415.51
Jul 2416.57
Jul 2416.71
Jul 2416.76
Jul 2416.74
Jun 2416.75
Jun 2416.06
Jun 2416.28
Jun 2416.15
May 2417.4
May 2412.68
May 2413.18
May 2414.45
May 2413.75
Apr 2413.67
Apr 2413.73
Apr 2414.08
Apr 2414.21
Mar 2414.22
Mar 2414.17
Mar 2414.34
Mar 2414.74
Mar 2414.85
Feb 2419.27
Feb 2419.36
Feb 2419.82
Feb 2418.75
Jan 2419.92
Jan 2419.9
Jan 2420.15
Jan 2419.53
Dec 2320.01
Dec 2319.92
Dec 2319.76
Price/Operating Cashflow
0204060med 2.36Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
BIOX Price/Operating Cashflow by quarter
PeriodPrice/Operating Cashflow
Sep 260.47
Sep 260.46
Sep 260.47
Aug 260.45
Aug 260.48
Aug 260.49
Aug 260.37
Jul 260.39
Jul 260.37
Jul 260.38
Jul 260.37
Jul 260.36
Jun 260.36
Jun 260.41
Jun 260.46
Jun 260.46
May 260.48
May 260.45
May 260.47
May 260.36
May 260.36
Apr 260.42
Apr 260.46
Apr 260.43
Apr 260.42
Mar 260.3
Mar 260.29
Mar 260.41
Mar 260.57
Feb 260.6
Feb 260.64
Feb 260.63
Feb 260.61
Jan 260.9
Jan 261.29
Jan 261.38
Jan 261.35
Jan 261.45
Dec 251.42
Dec 251.5
Dec 251.68
Dec 251.61
Nov 251.85
Nov 251.89
Nov 252.13
Nov 252.42
Oct 252.75
Oct 252.49
Oct 252.3
Oct 251.94
Oct 251.81
Sep 252.03
Sep 252.26
Sep 252.76
Sep 253.67
Aug 253.78
Aug 253.97
Aug 253.99
Aug 254.2
Aug 254.7
Jul 255.08
Jul 254.89
Jul 255.73
Jul 256.69
Jun 256.08
Jun 256.15
Jun 2548.56
Jun 2555.99
May 2554.1
May 2551.33
May 2551.55
May 2552.22
May 2550.89
Apr 2547.67
Apr 2545.9
Apr 2548.34
Apr 2545.79
Mar 2554.32
Mar 2548.34
Mar 2551.33
Mar 2557.54
Feb 2544.57
Feb 258.9
Feb 259.7
Feb 2510.85
Jan 2513.4
Jan 2514.04
Jan 2513.47
Jan 2512.79
Jan 2512.52
Dec 2412.42
Dec 2412.1
Dec 2413.02
Dec 2412.69
Nov 2413.92
Nov 248.9
Nov 248.96
Nov 249.28
Nov 249.43
Oct 2444.1
Price to Book
00.511.5med 0.36Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
BIOX Price to Book by quarter
PeriodPrice to Book
Sep 260.3
Sep 260.29
Sep 260.3
Aug 260.28
Aug 260.31
Aug 260.31
Aug 260.24
Jul 260.25
Jul 260.24
Jul 260.24
Jul 260.24
Jul 260.23
Jun 260.23
Jun 260.26
Jun 260.29
Jun 260.29
May 260.31
May 260.29
May 260.3
May 260.28
May 260.28
Apr 260.32
Apr 260.35
Apr 260.33
Apr 260.32
Mar 260.23
Mar 260.22
Mar 260.31
Mar 260.12
Feb 260.13
Feb 260.14
Feb 260.13
Feb 260.13
Jan 260.19
Jan 260.27
Jan 260.29
Jan 260.29
Jan 260.31
Dec 250.3
Dec 250.32
Dec 250.36
Dec 250.34
Nov 250.39
Nov 250.32
Nov 250.36
Nov 250.33
Oct 250.37
Oct 250.33
Oct 250.31
Oct 250.26
Oct 250.24
Sep 250.27
Sep 250.3
Sep 250.37
Sep 250.49
Aug 250.51
Aug 250.53
Aug 250.54
Aug 250.56
Aug 250.63
Jul 250.68
Jul 250.66
Jul 250.77
Jul 250.9
Jun 250.82
Jun 250.83
Jun 250.79
Jun 250.92
May 250.89
May 250.84
May 250.84
May 250.85
May 250.83
Apr 250.78
Apr 250.75
Apr 250.79
Apr 250.75
Mar 250.89
Mar 250.79
Mar 250.84
Mar 250.94
Feb 250.73
Feb 250.83
Feb 250.9
Feb 251.01
Jan 251.24
Jan 251.3
Jan 251.25
Jan 251.19
Jan 251.16
Dec 241.15
Dec 241.12
Dec 241.21
Dec 241.18
Nov 241.29
Nov 241.06
Nov 241.07
Nov 241.11
Nov 241.13
Oct 241.26
Bioceres Crop Solutions Corp.
BIOX
Stockpicker

Video analysis: BIOX

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: BIOX

Bioceres Crop Solutions Reports Fiscal Fourth Quarter and Full-Year 2026 Financial and Operating Results

businesswire.com · 14 Sep 2026

Bioceres Crop Solutions Reports Fiscal Fourth Quarter and Full-Year 2026 Financial and Operating Results

ROSARIO, Argentina--(BUSINESS WIRE)--Bioceres Crop Solutions Corp. (Bioceres) (NASDAQ: BIOX), a leader in the development and commercialization of productivity solutions designed to regenerate agricultural ecosystems while making crops more resilient to climate change, announced financial results for the fiscal fourth quarter ended June 30, 2026. Financial results are expressed in U.S. dollars and are presented in accordance with International Financial Reporting Standards. All comparisons in t.

Bioceres Crop Solutions to Host Fiscal Fourth Quarter and Full Year 2026 Financial Results Conference Call on Tuesday, September 15, 2026 at 8:30 a.m. Eastern Time

businesswire.com · 9 Sep 2026

Bioceres Crop Solutions to Host Fiscal Fourth Quarter and Full Year 2026 Financial Results Conference Call on Tuesday, September 15, 2026 at 8:30 a.m. Eastern Time

ROSARIO, Argentina--(BUSINESS WIRE)--Bioceres Crop Solutions Corp. (NASDAQ: BIOX) (“Bioceres” or the “Company”), a leader in the development and commercialization of productivity solutions designed to regenerate agricultural ecosystems while making crops more resilient to climate change, will hold a conference call on Tuesday, September 15, 2026 at 8:30 a.m. Eastern Time to discuss its results for the fiscal fourth quarter and full year ended June 30, 2026. A press release detailing these resul.

Pinnacle Food Group (NASDAQ:PFAI) vs. Bioceres Crop Solutions (NASDAQ:BIOX) Head to Head Contrast

defenseworld.net · 22 Jul 2026

Pinnacle Food Group (NASDAQ:PFAI) vs. Bioceres Crop Solutions (NASDAQ:BIOX) Head to Head Contrast

Pinnacle Food Group (NASDAQ: PFAI - Get Free Report) and Bioceres Crop Solutions (NASDAQ: BIOX - Get Free Report) are both small-cap consumer staples companies, but which is the superior business? We will contrast the two businesses based on the strength of their dividends, institutional ownership, risk, earnings, profitability, analyst recommendations and valuation. Analyst Recommendations This is

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.